| Dr Walid Jamil Almuti, MD | |
|
19841 N 27th Ave Ste 403, Phoenix, AZ 85027 | |
| (602) 439-0274 | |
| (602) 938-3189 |
| Full Name | Dr Walid Jamil Almuti |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 25 Years |
| Location | 19841 N 27th Ave Ste 403, Phoenix, Arizona |
| Accepts Medicare Assignments | May be. He may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588717334 | NPI | - | NPPES |
| 096444 | Other | OH | STATE LICENSE |
| 35819 | Other | AZ | MEDICAL LIC NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | 35.096444 (Ohio) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Honorhealth Deer Valley Medical Center | Phoenix, AZ | Hospital |
| Banner Boswell Medical Center | Sun city, AZ | Hospital |
| Banner Thunderbird Medical Center | Glendale, AZ | Hospital |
| Entity Name | Infectious Disease Consultants Of Arizona |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811320203 PECOS PAC ID: 5799909289 Enrollment ID: O20140624002553 |
News Archive
Women who receive a contraceptive known as an intrauterine device or IUD immediately following a first trimester abortion experience few complications and are less likely to have an unintended pregnancy than those who delay getting an IUD by several weeks, according to a new study at Oregon Health & Science University.
Electromed, Inc. today announced financial results for the three months ended September 30, 2010. Net revenues for the three months ended September 30, 2010 were approximately $4,165,000, a 29% increase compared to net revenues of approximately $3,228,000 for the same period last year.
Syndax Pharmaceuticals, Inc., a late-stage oncology company focused on the clinical development of epigenetic therapies in solid tumors, announced that previously reported results from ENCORE 401, a randomized, placebo controlled Phase 2 study of erlotinib with or without entinostat in advanced non-small cell lung cancer patients were published in the Journal of Clinical Oncology (JCO).
Each year, between 50 and 85 percent of health center patients - or between ten and seventeen million people - experience unmet legal needs, many of which negatively impact their health, according to a new study from the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at The George Washington University School of Public Health and Health Services.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Walid Jamil Almuti, MD 12747 N 57th Dr, Glendale, AZ 85304-1879 Ph: () - | Dr Walid Jamil Almuti, MD 19841 N 27th Ave Ste 403, Phoenix, AZ 85027 Ph: (602) 439-0274 |
News Archive
Women who receive a contraceptive known as an intrauterine device or IUD immediately following a first trimester abortion experience few complications and are less likely to have an unintended pregnancy than those who delay getting an IUD by several weeks, according to a new study at Oregon Health & Science University.
Electromed, Inc. today announced financial results for the three months ended September 30, 2010. Net revenues for the three months ended September 30, 2010 were approximately $4,165,000, a 29% increase compared to net revenues of approximately $3,228,000 for the same period last year.
Syndax Pharmaceuticals, Inc., a late-stage oncology company focused on the clinical development of epigenetic therapies in solid tumors, announced that previously reported results from ENCORE 401, a randomized, placebo controlled Phase 2 study of erlotinib with or without entinostat in advanced non-small cell lung cancer patients were published in the Journal of Clinical Oncology (JCO).
Each year, between 50 and 85 percent of health center patients - or between ten and seventeen million people - experience unmet legal needs, many of which negatively impact their health, according to a new study from the Geiger Gibson/RCHN Community Health Foundation Research Collaborative at The George Washington University School of Public Health and Health Services.
› Verified 7 days ago
Moustafa I Hazin, D.O. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 500 W Thomas Rd, Suite 900, Phoenix, AZ 85013 Phone: 602-406-5590 Fax: 602-406-7165 | |
Dr. Ali Shaheen Al-yaqoobi, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 2601 E Roosevelt St, Phoenix, AZ 85008 Phone: 602-344-5411 | |
Dana Archbold, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 1111 E Mcdowell Rd, Phoenix, AZ 85006 Phone: 602-839-2296 Fax: 602-839-2084 | |
Catalina Nicole Flores, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 350 W Thomas Rd Dept Of, Phoenix, AZ 85013 Phone: 602-406-3000 | |
Kristina Yancey, Infectious Disease Medicare: Medicare Enrolled Practice Location: 5777 E Mayo Blvd, Phoenix, AZ 85054 Phone: 480-342-2000 | |
Dr. Francisco Cordova, MD Infectious Disease Medicare: Medicare Enrolled Practice Location: 29 W Edgemont Ave, Phoenix, AZ 85003 Phone: 602-263-8971 Fax: 602-263-8971 | |
Dr. Dimpy Kapoor, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 9305 W Thomas Rd, Ste 455, Phoenix, AZ 85037 Phone: 623-399-9010 Fax: 623-399-9013 |